Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Multiple Sclerosis Healthy Subjects”

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT04982991
What this trial is testing

Single Ascending Dose Study of SAR443820 in Healthy Adult Chinese and Japanese Female and Male Participants

Who this might be right for
Multiple Sclerosis Healthy Subjects
Sanofi 14
Early research (Phase 1)Study completedNCT04941781
What this trial is testing

PET Study to Determine the Relationship Between Plasma Concentrations and Muscarinic Type 1 Receptor (M1AChR) Occupancy of PIPE-307 in Healthy Volunteers

Who this might be right for
Multiple Sclerosis
Contineum Therapeutics 6
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07826689
What this trial is testing

A Phase 1/2a Study of Oral PRO-1562 in Healthy Subjects and Patients With Relapsing Multiple Sclerosis

Who this might be right for
Multiple Sclerosis
Progentos Therapeutics 160
Early research (Phase 1)Study completedNCT02046629
What this trial is testing

Evaluate the Pharmacokinetic Profiles of Single 14 mg Teriflunomide Tablet in Healthy Chinese Volunteers

Who this might be right for
Multiple Sclerosis
Sanofi 12
Early research (Phase 1)Ended earlyNCT01808482
What this trial is testing

A First Time in Human Study Exploring Safety, Tolerability, Pharmacokinetics (PK) and Pharmacodynamics (PD) of GSK2618960 in Healthy Volunteers and Patients With Relapsing Remitting Multiple Sclerosis (RRMS)

Who this might be right for
Multiple Sclerosis, Relapsing-Remitting
GlaxoSmithKline 16
Early research (Phase 1)Study completedNCT01416363
What this trial is testing

Healthy Volunteer Study Using 3 Different Formulations of Firategrast

Who this might be right for
Multiple Sclerosis, Relapsing-Remitting
GlaxoSmithKline 38
Early research (Phase 1)Active Not RecruitingNCT05279755
What this trial is testing

Evaluate the Safety and Pharmacokinetics of Single and Multiple Doses of Prosetin in Healthy Volunteers and Participants With ALS

Who this might be right for
Amyotrophic Lateral Sclerosis
ProJenX 72
Early research (Phase 1)Study completedNCT01424163
What this trial is testing

Dexpramipexole Japanese PK Study

Who this might be right for
Amyotrophic Lateral Sclerosis
Knopp Biosciences 57
Not applicableStudy completedNCT02287948
What this trial is testing

Wii FIT Balance Board to Recording Balance Parameters in Multiple Sclerosis Subjects

Who this might be right for
Postural BalanceMultiple Sclerosis
University Hospital of Ferrara 40
Early research (Phase 1)Study completedNCT01863069
What this trial is testing

Avonex®: Safety, Blood Levels and Effects

Who this might be right for
Multiple Sclerosis (MS)
Trio Medicines Ltd. 77
Early research (Phase 1)Looking for participantsNCT07221240
What this trial is testing

Study to Evaluate Safety, Tolerability, and Pharmacokinetics of Amisodin in Healthy Adult Subjects With Amyotrophic Lateral Sclerosis

Who this might be right for
Amyotrophic Lateral Sclerosis
PRG Science & Technology Co., Ltd. 48
Early research (Phase 1)Study completedNCT05432713
What this trial is testing

LP-168 in Healthy Volunteers

Who this might be right for
Multiple SclerosisNMO Spectrum Disorder
Guangzhou Lupeng Pharmaceutical Company LTD. 70
Early research (Phase 1)Study completedNCT05983939
What this trial is testing

Study Evaluating Safety and Tolerability of Escalating Single and Multiple Doses of PIPE-791 and Food Effect in Healthy Volunteers

Who this might be right for
Multiple Sclerosis
Contineum Therapeutics 56
Early research (Phase 1)Study completedNCT01387217
What this trial is testing

GSK2018682 FTIH in Healthy Volunteers

Who this might be right for
Multiple Sclerosis
GlaxoSmithKline 27
Not applicableStudy completedNCT00393588
What this trial is testing

Magnetic Resonance Imaging to Detect Brain Damage in Patients With Multiple Sclerosis

Who this might be right for
Multiple Sclerosis
National Institute of Neurological Disorders and Stroke (NINDS) 50
Early research (Phase 1)Study completedNCT02641041
What this trial is testing

Safety, Tolerability, and Pharmacokinetics of Single and Multiple Doses of BIIB033 in Healthy Japanese Participants

Who this might be right for
Central Nervous System (CNS) Demyelinating DiseaseMultiple Sclerosis
Biogen 24
Early research (Phase 1)Study completedNCT03954600
What this trial is testing

Assess the Safety, Tolerability and PK of NPT520-34 in Healthy Subjects

Who this might be right for
Healthy Volunteers
Neuropore Therapies Inc. 49
Early research (Phase 1)Study completedNCT01424462
What this trial is testing

Healthy Volunteer Pilot Study Using 3 Types of Modified Release Formulations of Firategrast to Investigate How Quickly Absorption From the Digestive System Takes Place.

Who this might be right for
Multiple Sclerosis, Relapsing-Remitting
GlaxoSmithKline 20
Not applicableLooking for participantsNCT00794352
What this trial is testing

Comprehensive Multimodal Analysis of Neuroimmunological Diseases of the Central Nervous System

Who this might be right for
Central Nervous System DiseaseMultiple Sclerosis
National Institute of Allergy and Infectious Diseases (NIAID) 2,400
Not applicableLooking for participantsNCT06826638
What this trial is testing

Unraveling Active Ingredients of Neurorehabilitation: Investigating Cortical Activity During Task-oriented Exercises

Who this might be right for
Multiple SclerosisHealthy Volunteer
Fondazione Don Carlo Gnocchi ETS 40
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation